Pilot clinical trials testing the safety and effects on the metastatic melanoma microenvironment of intratumoral interferon-gamma or imiquimod, plus a multipeptide melanoma vaccine

Antzeko izenburuak

• Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases
  nork: Mauldin, Ileana S., et al.
  Argitaratua: (2016)
• Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases
  nork: Mauldin, Ileana S., et al.
  Argitaratua: (2016)
• A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patients
  nork: Melssen, Marit M., et al.
  Argitaratua: (2019)
• Randomized Multicenter Trial of the Effects of Melanoma-Associated Helper Peptides and Cyclophosphamide on the Immunogenicity of a Multipeptide Melanoma Vaccine
  nork: Slingluff, Craig L., et al.
  Argitaratua: (2011)
• Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist
  nork: Meneveau, Max O, et al.
  Argitaratua: (2021)